The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant interest within the UK , prompting a notable shift in medication trends. Access these compounds remains a complex challenge , with NHS coverage currently limited and specialist practices offering prescriptions at a substantial price. Worries are being raised